Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

With 199 total subjects enrolled in the Prurisol Phase 2b trial the results are expected to be statistically significant.

http://www.ipharminc.com/press-release/2017/12/21/innovation-pharmaceuticals-completes-final-patient-visit-in-phase-2b-study-of-oral-prurisol-for-psoriasis

IPIX's Prurisol is following the FDA approved 505(b)(2) regulatory pathway.

With excellent topline statistically significant results and with the 505(b)(2) regulatory pathway, the FDA may allow IPIX to begin selling Prurisol via doctor's prescription while a Phase 3 trial is begun and progressing to completion.

Good luck and GOD bless,

George